☆ 4.3 Article

Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A from the Bone Marrow

LEUKEMIA RESEARCH (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Editorial Material Hematology

T/myeloid MPAL: origin and pathogenesis

Matthew P. McCormack

Summary: Fishman et al have developed a preclinical model of T/myeloid mixed phenotype acute leukemia (MPAL), which accurately mimics the human disease using a fusion oncoprotein identified in this leukemia subtype. This study provides valuable insights into the cellular origin and molecular pathogenesis of this disease, and offers a preclinical model for testing new therapeutics.

BLOOD (2022)

添加到收藏夹

Article Hematology

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML

Olga K. Weinberg et al.

Summary: This study evaluated the clinicopathologic features and outcomes of AML and MDS patients with complex karyotype (CK). The presence of TP53 mutation, especially multihit TP53 mutation, in the context of CK, identified a homogeneously aggressive disease, irrespective of blast count or therapy-relatedness.

BLOOD ADVANCES (2022)

添加到收藏夹

Article Hematology

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Hartmut Doehner et al.

Summary: The 2010 and 2017 editions of the European LeukemiaNet recommendations for AML diagnosis and management are widely recognized. There have been major advances in our understanding of AML, including disease classification updates, improvements in genomic diagnostics, and the development of new therapeutic agents. This update includes a revised genetic risk classification, response criteria, and treatment recommendations.

BLOOD (2022)

添加到收藏夹

Article Hematology

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber et al.

Summary: In 2016, the WHO, Society for Hematopathology, and European Association for Haematopathology collaborated to update the classification of myeloid neoplasms and acute leukemias, advancing the field of myeloid neoplasms and acute leukemias.

BLOOD (2022)

添加到收藏夹

Article Oncology

Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)

Eulalia Genesca et al.

Summary: In adult T-cell acute lymphoblastic leukemia (T-ALL), patients with a complex karyotype characterized by >3 cytogenetic alterations have been identified as a high-risk subgroup with poor prognosis. These patients exhibit inferior response to therapy, decreased event-free survival, overall survival, and increased cumulative incidence of relapse, independent of other baseline characteristics and MRD level. Additional molecular analyses of these patients show a unique molecular profile that may help understand resistance mechanisms and assess potential novel targeted therapies for improving outcomes in adult T-ALL patients.

LEUKEMIA RESEARCH (2021)

添加到收藏夹

Review Oncology

Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment

Thomas B. Alexander et al.

Summary: Mixed phenotype acute leukemia (MPAL) is a rare subtype of acute leukemia with features of both acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Recent collaborative efforts have made progress in understanding the genomic landscape and optimal therapy for MPAL, with a preponderance of retrospective data supporting beginning therapy with ALL directed regimens. Differences in prognosis for adult and children with MPAL have led to divergent approaches for therapy intensity, including use of stem cell transplantation consolidation.

CURRENT ONCOLOGY REPORTS (2021)

添加到收藏夹

Article Medical Laboratory Technology

Update on Acute Leukemias of Ambiguous Lineage

Nidhi Aggarwal et al.

CLINICS IN LABORATORY MEDICINE (2021)

添加到收藏夹

Review Medical Laboratory Technology

The genomic and biological complexity of mixed phenotype acute leukemia

Claire Andrews et al.

Summary: Mixed phenotype acute leukemia (MPAL) is a heterogeneous group of leukemias characterized by antigen expression on blasts of both myeloid and lymphoid lineage. While the biology of the majority of MPAL remains unclear, recent studies have started to explore the genomic and epigenetic landscape to refine the WHO classification. Treatment decisions are complicated due to lack of classification and prospective studies, with acute lymphoblastic leukemia-type therapy showing promising results and potential benefit of allogenic stem cell transplantation in certain patients. Collaborative multi-center studies may provide more conclusive answers to the questions surrounding this poorly understood disease.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2021)

添加到收藏夹

Article Oncology

RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD

Ali Sakhdari et al.

CANCER MEDICINE (2020)

添加到收藏夹

Review Genetics & Heredity

AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances

Kristin L. Koenig et al.

GENES (2020)

添加到收藏夹

Review Hematology

An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL)

Maliha Khan et al.

ANNALS OF HEMATOLOGY (2018)

添加到收藏夹

Review Oncology

Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis

Maria Maruffi et al.

LEUKEMIA (2018)

添加到收藏夹

Article Hematology

Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations

Xiaoli Mi et al.

AMERICAN JOURNAL OF HEMATOLOGY (2018)

添加到收藏夹

Article Medicine, General & Internal

Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia

I. S. Piskunova et al.

TERAPEVTICHESKII ARKHIV (2018)

添加到收藏夹

Article Oncology

Prognostic Effect of Complex Karyotype, Monosomal Karyotype, and Chromosome 17 Abnormalities in B-Cell Acute Lymphoblastic Leukemia

Priya Khoral et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)

添加到收藏夹

Review Hematology

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Steven H. Swerdlow et al.

BLOOD (2016)

添加到收藏夹

Article Oncology

Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%

Verena Muehlbacher et al.

GENES CHROMOSOMES & CANCER (2014)

添加到收藏夹

Article Hematology

Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization

Sandra Heesch et al.

ANNALS OF HEMATOLOGY (2013)

添加到收藏夹

Article Oncology

Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome

Kalliopi N. Manola et al.

CANCER GENETICS (2013)

添加到收藏夹

Article Hematology

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

Frank G. Rueckner et al.

BLOOD (2012)

添加到收藏夹

Article Hematology

Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification

Estella Matutes et al.

BLOOD (2011)

添加到收藏夹

Review Oncology

Mixed-phenotype acute leukemia: historical overview and a new definition

O. K. Weinberg et al.

LEUKEMIA (2010)

添加到收藏夹

Article Hematology

Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital

Jeffrey E. Rubnitz et al.

BLOOD (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.